Gadolinium-based magnetic resonance contrast agents for neuroradiology: An overview

Magnetic Resonance Imaging Clinics of North America

Volumn 20, Issue 4, 2012, Pages 625-631

  Kanal, Emanuel ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Contrast agents; Gadolinium; MR imaging; Relaxivity

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOFOSVESET; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOTERIDOL; GADOVERSETAMIDE; GADOXETIC ACID;

CHELATION; CONTRAST ENHANCEMENT; DOSE CALCULATION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; EVIDENCE BASED MEDICINE; HUMAN; IMAGE QUALITY; LIGAND BINDING; MAGNETIC FIELD; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; REVIEW; SIGNAL NOISE RATIO; TISSUE DISTRIBUTION;

EID: 84867891642     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2012.08.004     Document Type: Review

References (6)

1. Pintaske J., Martirosian P., Graf H., et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006, 41(3):213-221.
2. Rohrer M., Bauer H., Mintorovitch J., et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005, 40:715-724.
3. Text, Table 10, Briefing Document for Gadobutrol Injection, NDA 201,277, Bayer HealthCare Pharmaceuticals, as submitted to the FDA Peripheral & Central Nervous System Drugs Advisory Committee, January 21, 2011.
4. Seidl Z., Vymazal J., Mechl M., et al. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT study). Am J Neuroradiol 2012, 33(6):1050-1058.
5. Laurent S., Elst L.V., Muller R.N. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006, 1:128-137.
6. Giesel F.L., von Tengg-Kobligk H., Wilkinson I.D., et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest Radiol 2006, 41(3):222-228.